Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Remmers

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Translational Andrology and Urology|March 30, 2018
Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS studyFrank-Jan H Drost, Antti Rannikko, Riccardo Valdagni, et al.
Journal of Personalized Medicine|December 16, 2020
Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted BiopsiesDaniël F Osses, Christian Arsov, Lars Schimmöller, et al.
Journal of Pediatric Urology|March 19, 2025
Prognostic surgical factors related to short term urethroplasty complications after Tubularized Incised urethral Plate Urethroplasty in distal- and mid-type hypospadias in the Dutch Hypospadias StudyFred van der Toorn, Rogier Schroeder, Robert de Gier, et al.
Translational Andrology and Urology|March 30, 2018
Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant diseaseIvo G Schoots, Daniel F Osses, Frank-Jan H Drost, et al.
European Urology Oncology|April 19, 2022
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS StudyHenk Benjamin Luiting, Sebastiaan Remmers, Egbert R Boevé, et al.
European Urology Open Science|February 1, 2024
Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?Beth Russell, Katharina Beyer, Ailbhe Lawlor, et al.
Journal of Medical Screening|February 10, 2021
Impact of cancer screening on metastasis: A prostate cancer case studyJane Lange, Sebastiaan Remmers, Roman Gulati, et al.
The Journal of Urology|March 10, 2020
Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical ProstatectomyHenk B Luiting, Pim J van Leeuwen, Sebastiaan Remmers, et al.
The Journal of Urology|June 27, 2020
Reply by AuthorsHenk B Luiting, Pim J van Leeuwen, Sebastiaan Remmers, et al.
European Urology Open Science|December 6, 2024
Assessing the Cause of Death for Men with Prostate Cancer Using Official Mortality Statistics or a Dedicated Cause of Death Committee: Results from 30-year ERSPC Rotterdam DataSebastiaan Remmers, Ivo I de Vos, Frederique B Denijs, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Translational Andrology and Urology|March 30, 2018
Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS studyFrank-Jan H Drost, Antti Rannikko, Riccardo Valdagni, et al.
Journal of Personalized Medicine|December 16, 2020
Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted BiopsiesDaniël F Osses, Christian Arsov, Lars Schimmöller, et al.
Journal of Pediatric Urology|March 19, 2025
Prognostic surgical factors related to short term urethroplasty complications after Tubularized Incised urethral Plate Urethroplasty in distal- and mid-type hypospadias in the Dutch Hypospadias StudyFred van der Toorn, Rogier Schroeder, Robert de Gier, et al.
Translational Andrology and Urology|March 30, 2018
Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant diseaseIvo G Schoots, Daniel F Osses, Frank-Jan H Drost, et al.
European Urology Oncology|April 19, 2022
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS StudyHenk Benjamin Luiting, Sebastiaan Remmers, Egbert R Boevé, et al.
European Urology Open Science|February 1, 2024
Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?Beth Russell, Katharina Beyer, Ailbhe Lawlor, et al.
Journal of Medical Screening|February 10, 2021
Impact of cancer screening on metastasis: A prostate cancer case studyJane Lange, Sebastiaan Remmers, Roman Gulati, et al.
The Journal of Urology|March 10, 2020
Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical ProstatectomyHenk B Luiting, Pim J van Leeuwen, Sebastiaan Remmers, et al.
The Journal of Urology|June 27, 2020
Reply by AuthorsHenk B Luiting, Pim J van Leeuwen, Sebastiaan Remmers, et al.
European Urology Open Science|December 6, 2024
Assessing the Cause of Death for Men with Prostate Cancer Using Official Mortality Statistics or a Dedicated Cause of Death Committee: Results from 30-year ERSPC Rotterdam DataSebastiaan Remmers, Ivo I de Vos, Frederique B Denijs, et al.
Pageof 10